Annual Report 2018

Financials

Financial Highlights

The American Chemical Society (ACS) ended 2018 with solid financial results, marking its 15th consecutive year of positive operating performance, generating a change in net assets without donor restrictions from operations of $42.1 million on total revenues of $605.0 million. The favorable operating performance was attributable to a combination of strong financial results from the information services divisions and a continued emphasis on expense management across all Society program and administrative units.

The Society’s overall financial position strengthened in 2018, with net assets without donor restrictions increasing from $325.3 million at Dec. 31, 2017, to $326.9 million as of Dec. 31, 2018. This increase is attributed to the $42.1 million change in net assets without donor restrictions from operations, net investment losses of $27.9 million and a $12.6 million charge related to the funded position of the Society’s postretirement benefit plans. With the increase in net assets without donor restrictions, for the second time in a decade, the Society ended 2018 in full compliance with all of the ACS Board-approved financial guidelines.

The audited financial statements and additional financial information on the Society can be accessed here.

ACS is grateful for the generous support provided by donors and sponsors for its programs and awards. To see the names of those who contributed, please view the list of donors in the 2018 Progress Report and the list of 2018 sponsors of ACS national awards.